Wilkerson L A
Center for Family Practice & Sports Medicine, Kissimmee, FL 34741-4100, USA.
J Am Osteopath Assoc. 1998 Apr;98(4):211-5.
Exercise-induced asthma is the phenomenon of transient airflow obstruction, typically 5 to 15 minutes after physical exertion. The increased airway resistance produces a 15% or greater decrease in the forced expiratory volume in 1 second, or in peak expiratory flow rate. Exercise-induced asthma occurs in 90% of individuals with asthma, representing 12% to 15% of the population world-wide. The prevalence of exercise-induced asthma among athletes ranges between 3% and 11%. Several theories of the etiology exist: respiratory heat or water loss (or both), hyperventilation causing discharge of bronchospastic chemical mediators or rebound rewarming of the blood in airway tissues. Treatment is either by pharmacologic or nonpharmacologic means, but medication continues to be the cornerstone of therapy for exercise-induced asthma. beta 2-Specific agonists remain the drugs of choice. Cromolyn sodium and nedocromil sodium are alternatives to the beta 2-agonists, and the combined use of the two classes of agents can provide additive benefits.
运动诱发性哮喘是一种短暂气流受限现象,通常在体力活动后5至15分钟出现。气道阻力增加会导致一秒用力呼气量或呼气峰值流速下降15%或更多。90%的哮喘患者会发生运动诱发性哮喘,占全球人口的12%至15%。运动员中运动诱发性哮喘的患病率在3%至11%之间。病因有多种理论:呼吸道热量或水分流失(或两者皆有)、过度通气导致支气管痉挛化学介质释放或气道组织中血液的反弹性复温。治疗方法包括药物治疗或非药物治疗,但药物仍然是运动诱发性哮喘治疗的基石。β2特异性激动剂仍然是首选药物。色甘酸钠和奈多罗米钠是β2激动剂的替代药物,两类药物联合使用可提供附加益处。